UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 17, 2012
REMEDENT, INC.
(Exact name of Registrant as Specified in its Charter)
|
Nevada (State or Other Jurisdiction of Incorporation) |
001-15975 (Commission File Number) |
86-0837251 (IRS Employer Identification No.) |
|
BelgiumZuiderlaan 1-3 bus 8, 9000 Ghent, Belgium (Address of Principal Executive Offices) |
N/A (Zip Code) |
011-329-321-7080
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 5—Corporate Governance and Management.
Item 5.02 . Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 17, 2012, Mr. Stephen Ross, the Company’s Chief Financial Officer and Director, tendered his resignation as an officer and director of the Company, effective on July 17, 2012.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| REMEDENT, INC., | |||
| a Nevada corporation | |||
| Dated: July 17, 2012 | By: | /s/ Stephen Ross | |
|
Stephen Ross Chief Financial Officer |
|||